A Chinese hospital, affiliated with the Chinese Academy of Medical Sciences (CAMS), has pioneered a cutting-edge radiation-free percutaneous intervention for the treatment of heart disease, marking a significant leap forward in cardiovascular care. This is reported by CGTN, a partner of TV BRICS.

This innovative procedure leverages ultrasound imaging to guide minimally invasive instruments through peripheral blood vessels directly to the heart. Unlike conventional methods, this approach eliminates the need for surgical incisions and radiation exposure, allowing patients to remain conscious throughout. It is particularly beneficial for pregnant women, allergy sufferers, and cancer patients, as it avoids the risks associated with radiation. Moreover, this treatment does not rely on costly imported equipment, making it both cost-effective and technically accessible.

To date, the hospital has developed more than 17 new methods for treating cardiovascular diseases, including congenital heart defects, valve disorders, and arrhythmias, with 65 patents granted in recognition of their innovations. The hospital has also designed an array of therapeutic tools, such as ultrasound catheters and surgical robots, with 23 of these devices now available both in China and abroad.

This groundbreaking procedure is expected to bolster primary healthcare services by providing effective cardiovascular treatment for outpatients. It will also significantly expand access to life-saving cardiovascular care in countries and regions with limited healthcare resources. Importantly, this novel form of cardiovascular treatment has received funding support from the United Nations.

The hospital's medical teams are extending their expertise globally, delivering Chinese solutions for cardiovascular care in over 30 countries, including Russia, and Kenya.

Photo: iStock